Beta
42462

Hearing screening in neonates receiving Vancomycin in the Neonatal Intensive Care Units

Thesis

Last updated: 06 Feb 2023

Subjects

-

Tags

Pediatrics

Advisors

El-Attar, Muna M. , Abdel-Lattif, Dalya A. , El-Shennawi, Amira M.

Authors

El-Shazli, Waad Muhammad El-Sayed

Accessioned

2017-07-12 06:41:13

Available

2017-07-12 06:41:13

type

M.Sc. Thesis

Abstract

Background: Hearing impairment is the most common congenital defect, acquired hearing loss may develop as side effect of using ototoxic drugs. Aim of the work: To assess the effect of vancomycin on hearing of newborns admitted to NICU. methods: this case control study included 100 neonate (50 received vancomycin) and ( 50 didn’t receive vancomycin). History, investigations done during admission& OAE tests were done. Results: OAE tests were normal in both groups indicating vancomycin not ototoxic. conclusion: Using vancomycin is not ototoxic to neaonates when used in standard dose and duration.

Issued

1 Jan 2014

DOI

http://dx.doi.org/10.21473/iknito-space/36399

Details

Type

Thesis

Created At

05 Feb 2023